- The trend backdrop is active with a 28-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
CRDA
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Croda International Plc · Basic Materials · Specialty Chemicals
Latest close
3,265 GBP
1.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 11.7% above the Trend Line and sits at 90.6% of its 52-week range. The latest completed week returned 1.9%, after a 12.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high.
Setup score
71
out of 100
Latest Close
3,265 GBP
7 Aug 2026
1W Return
1.9%
latest completed week
4W Return
12.7%
short-term follow-through
12W Return
18.4%
quarterly tape
Trend Breadth
53.8%
28 of 52 weeks active
Volume Ratio
1.9x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 44.11% based on similar historical setup states.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.9%
Latest completed week; four-week move 12.7%.
Indicator stack
75/62
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.11%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
22 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 11.7% above the Trend Line and sits at 90.6% of its 52-week range. The latest completed week returned 1.9%, after a 12.7% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5912-week average 0.55
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.7% over four weeks, 18.4% over 12 weeks, and 24.3% over one year. The current trend has remained active for 28 consecutive weeks.
Performance by holding period
Active trend streak28 weeks
Active weeks in one year28
Trend breadth53.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.68Latest activity-pressure read.
Pressure change-8.3%Four-week change in activity pressure.
Leadership6.19Latest relative-leadership reading.
RS change313.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength16/100Blend of value, momentum, and quality. Underlying universe rank 85; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality15/100Profitability and accounting quality. Underlying universe rank 86; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth5/100Revenue and earnings growth. Underlying universe rank 96; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework22/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 73.4x Price divided by trailing earnings.
- Price / sales
- 2.7x Market value relative to trailing revenue.
- EV / EBITDA
- 19.9x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 43.9% Gross profit retained from each unit of revenue.
- Operating margin
- 15.3% Operating profit retained from revenue.
- Free-cash-flow margin
- 9.8% Free cash flow generated from revenue.
- Return on invested capital
- 7.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.4% Latest one-year revenue growth.
- EPS growth
- -60.8% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 21.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 3.4% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 3.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 22 relevant articles.
6 positive · 16 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.6%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+11.0%Week of 27 Mar.
Worst week-13.5%Week of 13 Mar.
Latest week+1.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains11
Flat weeks0
Modest losses4
Sharp losses5
Recent vol4.3%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Basic Materials
4-week rank29 / 100
Group average5.9%
Trend breadth26.0%
Trend26.0%active weekly trend signals
MD33.0%positive activity pressure
RS43.0%positive relative leadership
Four-week leaders
IndustryGB Specialty Chemicals
4-week rank8 / 12
Group average19.9%
Trend breadth41.7%
Trend41.7%active weekly trend signals
MD58.3%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape67/100
Trend, activity pressure, participation, and risk combine to a 67/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 12/12, activity pressure 9/12, relative leadership 6/12.
Activity pressure 0.59; No reversal markers Next-Week ExpectancyNegative 44.11%Next-week expectancy is negative with a 44.11% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors28/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 73 SVQF22/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 202.0 of 260 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 22 relevant articles.
Croda International (LON:CRDA) Sets New 1-Year High - Here's What Happened Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 3,265 GBP | 1.9% | 2,922 GBP | 3,615 GBP | 0.68 | 6.19 | 2.7M | On |
| 31 Jul 2026 | 3,205 GBP | 9.3% | 2,905 GBP | 3,630 GBP | 0.29 | 4.62 | 2.8M | On |
| 24 Jul 2026 | 2,932 GBP | 0.1% | 2,889 GBP | 3,648 GBP | 0.09 | -3.26 | 1.3M | On |
| 17 Jul 2026 | 2,928 GBP | 1.1% | 2,885 GBP | 3,665 GBP | 0.43 | -2.44 | 1.8M | On |
| 10 Jul 2026 | 2,897 GBP | -4.9% | 2,878 GBP | 3,683 GBP | 0.75 | -2.90 | 1.7M | On |
| 3 Jul 2026 | 3,045 GBP | 0.8% | 2,872 GBP | 3,700 GBP | 0.79 | -0.11 | 131.1K | On |
| 26 Jun 2026 | 3,020 GBP | -3.1% | 2,861 GBP | 3,716 GBP | 0.54 | 0.29 | 516.9K | On |
| 19 Jun 2026 | 3,118 GBP | 2.2% | 2,851 GBP | 3,733 GBP | 0.36 | 4.61 | 1.0M | On |
| 12 Jun 2026 | 3,052 GBP | 5.2% | 2,841 GBP | 3,748 GBP | 0.03 | 1.03 | 690.1K | On |
| 5 Jun 2026 | 2,901 GBP | -4.6% | 2,832 GBP | 3,762 GBP | -0.20 | -3.34 | 208.9K | On |
| 29 May 2026 | 3,041 GBP | 1.7% | 2,832 GBP | 3,783 GBP | -0.15 | 0.46 | 2.1M | On |
| 22 May 2026 | 2,991 GBP | 8.5% | 2,831 GBP | 3,804 GBP | -0.22 | -2.11 | 1.7M | On |
| 15 May 2026 | 2,757 GBP | -3.1% | 2,827 GBP | 3,825 GBP | -0.09 | -7.81 | 1.8M | On |
| 8 May 2026 | 2,845 GBP | 0.4% | 2,826 GBP | 3,851 GBP | 0.22 | -5.79 | 1.8M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.